VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $239,747,000 | -19.6% | 1,344,024 | +0.1% | 5.42% | -18.9% |
| Q2 2015 | $298,251,000 | +11.7% | 1,342,567 | -0.1% | 6.68% | +3.3% |
| Q1 2015 | $266,939,000 | +72.0% | 1,343,970 | +23.9% | 6.47% | +99.4% |
| Q4 2014 | $155,175,000 | -25.2% | 1,084,304 | -31.4% | 3.24% | -18.5% |
| Q3 2014 | $207,513,000 | +4.1% | 1,581,651 | +0.0% | 3.98% | -2.0% |
| Q2 2014 | $199,434,000 | +10.1% | 1,581,304 | +15.1% | 4.07% | -4.2% |
| Q1 2014 | $181,077,000 | +0.9% | 1,373,567 | -10.1% | 4.24% | -8.4% |
| Q4 2013 | $179,458,000 | +45.1% | 1,528,603 | +29.0% | 4.63% | +31.5% |
| Q3 2013 | $123,655,000 | +21.2% | 1,185,229 | 0.0% | 3.52% | +18.6% |
| Q2 2013 | $102,025,000 | – | 1,185,229 | – | 2.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |